ANI Pharmaceuticals | ANIP - Equity Capital And Reserves


ANI Pharmaceuticals reported $597.21M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
ANI Pharmaceuticals USD 597.21M 34.91M Jun/2026
Aurora Cannabis CAD 511.83M 24.53M Mar/2026
Canopy Growth CAD 697.59M 60.58M Mar/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Heron Therapeutics USD 6.91M 2.23M Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Nektar Therapeutics USD 576.22M 486.38M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Omeros USD -228.68M 15.13M Jun/2025
Perrigo USD 2.52B 17M Jun/2026
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026